皓元医药 (ChemExpress)
Shanghai, CN · 1 known investors
Find your way into 皓元医药 (ChemExpress)
Sign up to see every warm intro you have to 皓元医药 (ChemExpress)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 皓元医药 (ChemExpress) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MedChemExpress (Shanghai Haoyuan Pharmaceutical, stock code 688131) is a CRO and CDMO that provides life-science research reagents and drug development, process optimization, and commercial manufacturing of APIs, intermediates, starting materials, and formulations for the global pharmaceutical and biotech industry. It offers an integrated platform covering small molecules, large molecules, and new molecular types from preclinical stages through commercial production.
Investors · 1
Frequently asked questions
- What does 皓元医药 (ChemExpress) do?
- MedChemExpress (Shanghai Haoyuan Pharmaceutical, stock code 688131) is a CRO and CDMO that provides life-science research reagents and drug development, process optimization, and commercial manufacturing of APIs, intermediates, starting materials, and formulations for the global pharmaceutical and biotech industry. It offers an integrated platform covering small molecules, large molecules, and new molecular types from preclinical stages through commercial production.
- Who are 皓元医药 (ChemExpress)'s investors?
- 皓元医药 (ChemExpress)'s investors include Addor Capital.
- Where is 皓元医药 (ChemExpress) headquartered?
- 皓元医药 (ChemExpress) is headquartered in Shanghai, CN.